Yüklüyor......
Precision medicine in lupus nephritis: can biomarkers get us there?
Patients with systemic lupus erythematosus (SLE) frequently develop lupus nephritis (LN), a condition that can lead to end stage kidney disease (ESKD). Multiple serum and urine biomarkers for LN have been proposed in recent years, yet none have become incorporated into clinical use. The majority of...
Kaydedildi:
| Yayımlandı: | Transl Res |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415919/ https://ncbi.nlm.nih.gov/pubmed/30179587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2018.08.002 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|